Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Company News

Management tracks: Medicines Co., Mallinckrodt, ArQule

March 19, 2019 10:38 PM UTC

The Medicines Co. (NASDAQ:MDCO) terminated the employment of Christopher Cox, EVP and chief corporate development officer, effective March 15. Details were not disclosed.

Mallinckrodt plc (NYSE:MNK) hired Bryan Reasons as CFO. He will succeed interim CFO George Kegler. Reasons was SVP and CFO at Impax Laboratories Inc. prior to its merger with Amneal Pharmaceuticals Inc. (NYSE:AMRX)...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article